🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In vivo CAR engineering for immunotherapy bit.ly/45dg5KV

The fascinating story of Thalidomide: how this most notorious drug on the planet, banned in the 1960s, made an incredible comeback and revolutionized the treatment of myeloma. I will also highlight one person whose role is not recognized: Without Dr. Leif Bergsagel there will

🚨 D-15 before the abstract submission deadline for CAR T day, the 9th International Symposium on CAR T cells! And yes – this is the first time ever we’re opening submissions! 🧬 If you're working on CAR T cell therapy, this is your moment to share your research and shape

🚨 Just over 1️⃣ month left to grab the early bird rate for CAR T day, the 9th International Symposium on CAR T cells! 🎟️ Register by June 30, 2025 to secure your spot at CAR T day — and enjoy preferential rates for this must-attend event dedicated to the latest in cell & gene

Latest issue of Bone Marrow Transplantation, a consensus paper on QC harmonization for 🇪🇺 locally-manufactured #CAR-T_cells rdcu.be/eostD Ibrahim Yakoub-Agha The EBMT ASH FOCIS International Union of Immunological Societies SFI Immunologie Monica Guzman Immunopaedia Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx Mohamad Mohty

🚨 Great news! The abstract submission deadline has been extended exceptionally! 🕒 You have 3 days more, until Monday, June 9th (at 11:59 PM CET) to submit your abstract. 📩 Submit here → [email protected] 📋 Guidelines → cartday.org/abstract-2025 💬 Don’t miss

🌍 CAR T day 2025 – get ready for your arrival! 🚆✈️ We’re excited to welcome you to CAR T day 2025, taking place on Thursday 11 & Friday 12 September 2025! 🎉 📍 Location: Faculté de Médecine – Pôle Recherche 1 Place de Verdun, 59000 Lille, France 🛣️ How to get to Lille?

🚨 Great news! We initially announced an extension until June 9th… but we’re giving you even more time! 🕒 You now have until Monday, June 23rd at 23h59 CET to submit your abstract. 📩 Submit here → [email protected] 📋 Guidelines → cartday.org/abstract-2025 💬

📣 The second edition of the EU CAR-T Handbook is here to advance clinical practice and education 📣 💡 Jointly developed by EBMT, European Hematology Association, and the GoCART_Coalition, it is a comprehensive, open-access resource covering the latest developments in the field of CAR-T — a

Whirlwind day at #EHA25 presenting first on eligibility + longterm safety of CAR-T in 2L LBCL and then receiving this years EHA Publication Award for our ICAHT work in the Presidential Session 🙌 Grateful to share these moments with friends, collaborators and fantastic mentors!

China has now surpassed all other countries in number of new oncology clinical trials launched each year, AND also number of novel active substances (NAS) for cancers launched. IQVIA iqvia.com/library/videos…

We’ve been talking about CAR T day for a few weeks now… and you still haven’t registered? Let’s shine a light on some of the exceptional speakers joining us to share their groundbreaking work and insights. This is the first in a 6-part series 🎯 🎙️ Meet: ➡️ Justin Eyquem (San

Long awaited results of #VERONA (PH3 of aza-ven vs aza) in higher risk MDS press release with negative top line results for OS. We unfortunately remain in the dreaded boulevard of broken dreams in higher risk #MDSsm. Subgroup analyses will be important. news.abbvie.com/2025-06-16-Abb…

We are happy to share our recently published clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and CAR T-cell therapy in chronic lymphocytic leukemia on behalf of #ASTCT Mehdi Hamadani, MD Mazyar Shadman, MD MPH Ambuj Kumar … pubmed.ncbi.nlm.nih.gov/40514010/

🚨 D-7 to register at a preferentiel rate for #CARTday! 🎉 👉 Register now and secure your spot! cartday.org/registration/ Key dates & fees: 🎟️ Early bird: Register by June 30, 2025 💡 Regular rate: Available from July 1 to September 5, 2025 📍 On-site rate: From September 6 to

Join the italian researcher Dr. Franco Locatelli for a cutting-edge presentation in the session "New data from clinical trials" chaired by Sophie Caillat-Zucman 📅 Thursday, September 11 🧪 10:40 – "GD2 CAR T for neuroblastoma and brain tumors in children" A world-renowned

CAR T-cell therapy in multiple myeloma: where are we now—and what’s next? Join two internationally renowned experts from Würzburg as they tackle some of the most pressing questions in MM treatment. 🎙️ Featuring: ➡️ Hermann Einsele (Würzburg, Germany) ➡️ Michael Hudecek

We wrap up our speaker series with two powerful sessions on Friday, September 12 🌐 Session: "Adaptive T cells therapy for solid tumors" Chaired by: 🔹OlivierBoyer (Rouen) 🔹Christophe Ferrand (Besançon) 🕠 12:00 "Innovative Solutions for overcoming access to CAR-T Cell

🗓️ Just two months to go before #CARTday 2025: are you ready? Get a head start and explore the interactive scientific program, your personal gateway to a world-class journey in CAR T innovation. 🌍✨ 👉 cartday.org/program-2/ With just a few clicks, you can: 🔍 Search for

⏳ Still not registered for #CARTday 2025? You can still join us at the regular rate: don’t miss out! 👉cartday.org/registration/ Here’s one more reason to be there: 🚀 Jasia Mahdi (Houston, USA) — part of the new generation shaping the future of CAR T innovation. 🧠 Thursday,